Hospital Clinic of Barcelona
hospitalclinic.orgTotal trials
315
Active
41
Phase 3
24
Total enrollment
2,076,588
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 6 of 6 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Intraarterial alteplase | — | — | — | — | — | 2 | |
| Dapagliflozin | — | — | — | — | — | 1 | |
| Multigene panel | — | — | — | — | — | 1 | |
| Generation of 3D Pancreatic Organoids | — | — | — | — | — | 1 | |
| Cord Blood Red Blood Cells | — | — | — | — | — | 1 | |
| Standard Adult Donor Red Blood Cells | — | — | — | — | — | 1 |
Next readouts
- 2025-03-31
- 2025-08-26
- 2026-11
- 2028-12
Top conditions
- Atrial Fibrillation12
- HIV Infections10
- Cirrhosis7
- HIV Infection7
- Obesity6
- Bipolar Disorder5
- Colorectal Cancer5
- Chronic Disease5
Frequently asked questions about Hospital Clinic of Barcelona
- How many clinical trials does Hospital Clinic of Barcelona have on ClinicalTrials.gov?
- Hospital Clinic of Barcelona is listed as the lead sponsor on 315 clinical trials in ClinicalTrials.gov, 41 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Hospital Clinic of Barcelona's trials are in Phase 3?
- 24 of Hospital Clinic of Barcelona's trials are in Phase 3, spread across 6 active drug programs.
- What therapeutic areas does Hospital Clinic of Barcelona focus on?
- Hospital Clinic of Barcelona's most-studied conditions on ClinicalTrials.gov are Atrial Fibrillation, HIV Infections, Cirrhosis, HIV Infection, Obesity.
- When are Hospital Clinic of Barcelona's next clinical trial readouts?
- Hospital Clinic of Barcelona has 4 upcoming primary-completion readouts tracked here; the soonest is “Effect of Dapagliflozin in Myocardial Fibrosis and Ventricular Function in Patients With a ST-segment Elevation Myocardial Infarction”, expected around 2025-03-31.